Abstract
Background Maternal mental health as an important precursor to reproductive and neonatal complications remains understudied in the US, particularly in the Southeastern region, despite high medical costs and maternal morbidity, and infant burden.
Objective This study sought to estimate the incidence of perinatal mental health disorders and the associated increased risk of leading pregnancy and infant complications.
Methods A population-based retrospective birth cohort of delivery hospitalizations and readmissions was constructed for birthing populations in South Carolina, 1999 to 2017. Prevalence rates were calculated for perinatal mood and anxiety disorders (PMAD), severe mental illness (SMI), and maternal mental disorders of pregnancy (MDP). Poisson regression models using generalized estimating equations were used to estimate adjusted relative risks for the association between mental health conditions and severe maternal morbidity (SMM), hypertensive disorders of pregnancy (HDP), gestational diabetes (GD), cesarean delivery (CD), preterm birth (PTB), and low-birth weight (LBW).
Results The most prevalent maternal mental condition was MDP (3.9%), followed by PMAD (2.7%) and SMI (0.13%). PMAD was associated with a higher risk of SMM, HDP, and CD, as well as a higher risk of PTB and LBW infants. SMI was associated with LBW, HDP, and CD. Pregnant populations with MDP were more at risk for SMM, PTB, HDP, LBW, and CD. Each maternal mental health outcome was associated with an elevated risk for hospital readmissions up to 45 days after delivery.
Discussion Results demonstrated the escalating burden of PMAD and MDP for pregnant populations over time with important consequences related to maternal and infant morbidity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of NC State University gave ethical approval for this work Ethics committee/IRB of Appalachian State University gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
email: risley.kendra{at}gmail.com
email: roym1{at}appstate.edu
email: kovachmm{at}appstate.edu
Data Availability
All data produced in the present work are contained in the manuscript
